Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Oviedo
Clinical trial register · Spain

Clinical Trials in Oviedo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Oviedo

233 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Santander, Santiago de Compostela, Barcelona, Coslada, Girona, Madrid, Málaga, Oviedo
2026-12-16
Not yet open
Digital Patient-Reported Assessment in Older Adults With Acute Leukemia
NCT07597590Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Fundación para la Investigación Biosanitaria del Principado de Asturias
Not applicable
20
Oviedo
2026-12
Not yet open
Women in Action: A Multicomponent Intervention for Older Women
NCT07860424Sarcopenia, Physical Inactivity, Menopause, Healthy Aging
Universidad de Oviedo
Not applicable
214
Oviedo
2026-11
Not yet open
Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer
NCT07717099Metastatic Hormone-Sensitive Prostate Cance
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Phase 2
50
Barcelona, Las Palmas de Gran Canaria, Madrid, Oviedo, Santander, Santiago de Compostela, Valencia, Valladolid
2026-09
Recruiting
AstraZeneca
Phase 3
1,500
A Coruña, Alzira, Barcelona, Ferrol, Lleida, Málaga, Oviedo, Segovia
2026-08-20
Recruiting
Eli Lilly and Company
Phase 3
1,000
Barcelona, Centelles, Madrid, Oviedo, Salamanca, Seville, Zamora
2026-08-14
Recruiting
Abbott Medical Devices
Observational
1,000
Oviedo, Barcelona
2026-07-02
Not yet open
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
101
Badalona, Barcelona, Granada, Jaén, Málaga, Oviedo, Pamplona, Valencia
2026-07-01
Recruiting
Prilenia
Phase 3
400
Barakaldo, Barcelona, Madrid, Oviedo, Seville
2026-07-01
Recruiting
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
NCT07504458Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA, Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
Quetzal Therapeutics
Phase 3
150
Palma de Mallorca, Badalona, Barcelona, Cáceres, Málaga, Oviedo, Valencia
2026-06-08
Recruiting
Biobizkaia Health Research Institute
Phase 4
100
Córdoba, Bilbao, Valladolid, Albacete, Barcelona, Madrid, Majadahonda, Oviedo
2026-05-25
Not yet open
Investigación en Hemofilia y Fisioterapia
Observational
250
Oviedo
2026-05-05
Not yet open
Investigación en Hemofilia y Fisioterapia
Not applicable
70
Oviedo
2026-03-27
Not yet open
Investigación en Hemofilia y Fisioterapia
Observational
70
Oviedo
2026-02-27
Not yet open
University of Oviedo
Observational
118
Oviedo
2026-02-22
Recruiting
University of Oviedo
Observational
96
Oviedo
2026-02-16
Active, closed
University of Oviedo
Observational
207
Oviedo
2026-02-13
Not yet open
University of Oviedo
Observational
100
Oviedo
2026-02-12
Active, closed
University of Oviedo
Observational
154
Oviedo
2026-02-12
Active, closed
University of Oviedo
Observational
134
Oviedo
2026-02-12
Recruiting
Eli Lilly and Company
Phase 3
1,000
Barcelona, Madrid, Oviedo, Salamanca, Zamora
2026-02-09
Active, closed
Kailera
Phase 3
1,270
Ferrol, Seville, Villamartín, Barcelona, Oviedo, Castilleja de la Cuesta, Madrid, Valencia
2026-01-12
Recruiting
Janssen Research & Development, LLC
Phase 3
258
Barcelona, Esplugues de Llobregat, Madrid, Manresa, Oviedo, Pamplona, Sabadell
2026-01-08
By invitation
University of Oviedo
Not applicable
60
Oviedo
2026-01-05
Recruiting
PMCF Study Fortilink-TS Ti
NCT07834736Degenerative Disc Disease Lumbar, Spondylolisthesis, Grade 1
BAAT Medical Products B.V.
Observational
50
Madrid, Oviedo
2026-01-01
Active, closed
Kailera
Phase 3
2,530
Ferrol, Seville, Villamartín, Barcelona, Oviedo, Castilleja de la Cuesta, Madrid, Valencia
2025-12-18
Recruiting
ArriVent BioPharma, Inc.
Phase 3
480
Palma, Barcelona, Málaga, Oviedo, Valencia
2025-12-17
Recruiting
Incyte Corporation
Phase 3
466
Alava, Badalona, Barcelona, Madrid, Málaga, Oviedo, Palma, Sabadell
2025-12-09
Recruiting
GlaxoSmithKline
Phase 3
450
Barcelona, Madrid, Oviedo, Seville, Valencia, Zaragoza
2025-12-03
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Badalona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Santander, Oviedo, Alicante, Barcelona, Burgos
2025-11-25
Recruiting
Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice
NCT07252765Type 2 Diabetes Mellitus (T2DM), Malnutrition, Malnourishment, Drug-Induced Diabetes
Outcomes'10
Observational
334
Santander, Huelva, Las Palmas de Gran Canaria, Madrid, Málaga, Oviedo, Seville, Valencia
2025-11-20
Recruiting
GlaxoSmithKline
Phase 2
363
Barcelona, Lleida, Madrid, MErida Badajoz, Oviedo, Valencia
2025-10-30
Recruiting
Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
NCT07168434IBS (Irritable Bowel Syndrome), IBS-D (Diarrhea-predominant), IBS, Mixed Symptoms
Biocodex
Phase 3
406
Barcelona, León, Madrid, Marbella, Málaga, Oviedo
2025-10-22
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Albacete, Alicante, Badalona, Burgos, Cáceres, Córdoba, Madrid, Oviedo
2025-10-17
Recruiting
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
Not applicable
1,200
Elche, Barcelona, Santander, Madrid, Oviedo, Toledo, Valencia
2025-10-08
Recruiting
Pfizer
Phase 2/3
982
Barcelona, Madrid, Oviedo, Málaga
2025-10-03
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Seville, Zaragoza, Burgos, Salamanca, Albacete, Madrid, Oviedo, Valencia
2025-09-26
Recruiting
Sanofi
Phase 4
218
Santander, Barcelona, Pozuelo de Alarcón, Oviedo, Madrid
2025-09-22
Active, closed
AstraZeneca
Phase 3
68
A Coruña, Badajoz, Barakaldo, Barcelona, Madrid, Málaga, Oviedo, Santander
2025-09-15
Not yet open
Federation Francophone de Cancerologie Digestive
Phase 2
300
Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Oviedo, Pamplona, Salamanca, San Carlos
2025-08-31
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
153
Oviedo, Santiago de Compostela, Pamplona
2025-08-21
By invitation
Outcomes'10
Observational
132
Alicante, Madrid, Oviedo, Palma de Mallorca
2025-08-15
Recruiting
AstraZeneca
Phase 3
700
Barcelona, Girona, Madrid, Majadahonda, Málaga, Oviedo, Sabadell, Santander
2025-08-06
Recruiting
Association for Innovation and Biomedical Research on Light and Image
Phase 4
120
Barcelona, Madrid, Oviedo, Valencia
2025-08-06
Recruiting
AstraZeneca
Phase 3
800
Badalona, Barcelona, Córdoba, El Palmar (Murcia), L'Hospitalet de Llobregat, Madrid, Málaga, Oviedo
2025-08-01
Recruiting
Investigación en Hemofilia y Fisioterapia
Observational
114
Oviedo
2025-07-31
Recruiting
Investigación en Hemofilia y Fisioterapia
Observational
109
Oviedo
2025-07-30
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
Exelixis
Phase 2/3
440
Barcelona, Madrid, Murcia, Oviedo, Santander, Santiago de Compostela, Seville, Valencia
2025-07-21
Recruiting
AstraZeneca
Phase 2
100
Barcelona, Elche, Madrid, Málaga, Ourense, Oviedo, Santander, Valencia
2025-07-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Badalona, Santander, Las Palmas de Gran Canaria, Oviedo, Barcelona, Madrid, Seville, Valencia
2025-07-16
Recruiting
Hoffmann-La Roche
Observational
700
Almería, Palma de Mallorca, Manresa, Puerto Real, Alcázar de San Juan, Santiago de Compostela, Oviedo, Reus
2025-07-15
Recruiting
Eli Lilly and Company
Phase 3
290
Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
2025-06-26
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
166
Barcelona, L'Hospitalet de Llobregat, Burgos, Granada, Madrid, Oviedo, Seville, Valencia
2025-06-12
Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals
Phase 3
240
L'Hospitalet de Llobregat, Oviedo, Barcelona, Madrid, Salamanca
2025-05-30
Recruiting
Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients
NCT06861361Symptomatic Severe Aortic Stenosis
Ceric Sàrl
Not applicable
1,180
Oviedo, Valladolid
2025-05-15
Not yet open
Physical Activity in Patients With Systemic Lupus Erythematosus
NCT06919250Lupus Erythematosus, Systemic
University of Oviedo
Observational
63
Oviedo
2025-03-31
Recruiting
Daiichi Sankyo
Phase 3
510
Burgos, Elche, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Oviedo, Pamplona
2025-03-27
Active, closed
Immutep S.A.S.
Phase 3
756
Badalona, Barcelona, Córdoba, Madrid, Málaga, Oviedo, Sabadell, Seville
2025-03-21
Not yet open
Efficacy of Shock Wave Therapy in Post-Stroke Muscle Spasticity Management
NCT06815328Stroke, Spasticity, Post-stroke, Muscle Hypertonia
University of Oviedo
Not applicable
50
Oviedo
2025-03-15
Recruiting
Fundación EPIC
Not applicable
200
Barakaldo, Oviedo, Valladolid
2025-03-14
Recruiting
Moleculin Biotech, Inc.
Phase 2/3
312
Barcelona, Oviedo, Madrid, Valencia
2025-03-12
Recruiting
Instituto de Investigación Marqués de Valdecilla
Observational
330
Santander, Alicante, Barcelona, Bilbao, Burgos, Madrid, Oviedo, Toledo
2025-03-01
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Barcelona, L'Hospitalet Del Llobregat, Madrid, Majadahonda, Marbella, Oviedo, Salamanca, Santander
2025-01-03
Active, closed
mAbxience Research S.L.
Phase 3
726
A Coruña, Barcelona, Madrid, Málaga, Murcia, Oviedo, Palma de Mallorca, Pontevedra
2024-12-30
Recruiting
A Mobile App to Reduce and/or Quit Cannabis Use
NCT06733792Cannabis Dependence
Alba González-Roz, PhD
Not applicable
120
Oviedo
2024-12-13
Recruiting
Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
NCT06180356Ovarian Cancer, Oligometastatic Disease, Serous Ovarian Tumor
MedSIR
Phase 2
30
A Coruña, Barakaldo, Barcelona, Girona, Jaén, Madrid, Málaga, Oviedo
2024-12-03
Active, closed
AbbVie
Observational
1,314
Málaga, L'Hospitalet de Llobregat, Leganés, Majadahonda, Oviedo, Seville, Barcelona, Madrid
2024-11-26
Active, closed
BioMarin Pharmaceutical
Phase 2
30
Santiago de Compostela, Oviedo
2024-11-22
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Barcelona, Madrid, Majadahonda, Oviedo, Seville, Valencia, Vigo
2024-11-22
Active, closed
Sanofi
Observational
143
Santiago de Compostela, Esplugues de Llobregat, Oviedo, Seville, Alicante, Barcelona, Madrid, Málaga
2024-11-14
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
180
Oviedo, Barcelona, Madrid
2024-11-03
Recruiting
Fundación EPIC
Not applicable
94
Barcelona, Gijón, Huelva, León, Lugo, Mérida, Oviedo, Pontevedra
2024-10-23
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Granada, Málaga, Palma, Badalona, Barcelona, El Palmar, Oviedo, Madrid
2024-09-18
Recruiting
Sacituzumab govitEcan in THYroid Cancers
NCT06235216Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer
Grupo Espanol de Tumores Neuroendocrinos
Phase 2
42
Barcelona, Ferrol, Hospitalet de Llobregat (Barcelona), Madrid, Murcia, Oviedo, Santander, Zaragoza
2024-09-13
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
130
Seville, A Coruña, El Palmar, Oviedo, Barcelona, Madrid, Valencia, Zaragoza
2024-09-11
Active, closed
Noema Pharma AG
Phase 2
164
Barcelona, Burgos, Madrid, Oviedo, Sant Cugat del Vallès, Seville
2024-09-10
Recruiting
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
NCT06370182Acute Ischemic Stroke From Large Vessel Occlusion
Anaconda Biomed S.L.
Not applicable
327
Barcelona, Madrid, Murcia, Oviedo
2024-09-09
Active, closed
Amgen
Phase 3
315
Alicante, Barcelona, Jaén, Madrid, Mataró, Málaga, Oviedo, Seville
2024-09-09
Recruiting
PETHEMA Foundation
Phase 2
106
Alicante, Barcelona, Córdoba, Las Palmas de Gran Canaria, Madrid, Marbella, Málaga, Oviedo
2024-09-02
Recruiting
Abbott Structural Heart Device Registry
NCT06590467Heart Diseases, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PFO - Patent Foramen Ovale
Abbott Medical Devices
Observational
2,500
Esplugues de Llobregat, Oviedo, Seville, Madrid
2024-08-21
Recruiting
AstraZeneca
Phase 3
1,018
Barcelona, El Palmar, Girona, Las Palmas de Gran Canaria, Madrid, Oviedo, Pamplona, Santander
2024-08-07
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
109
Santiago de Compostela, Barcelona, Bilbao, Majadahonda, Pamplona, Oviedo, Sabadell, Santa Cruz de Tenerife
2024-07-12
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Badalona, Córdoba, Oviedo, Barcelona, Valencia
2024-06-25
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
Madrid, Oviedo, Barcelona
2024-06-20
Active, closed
GlaxoSmithKline
Phase 3
88
A Coruña, Aravaca, BaracaldoVizcaya, Barcelona, Jaén, Las Palmas de Gran Canar, Madrid, Oviedo
2024-06-10
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Albacete, Barcelona, Las Palmas de Gran Canaria, Lleida, Madrid, Marbella, Oviedo, Salamanca
2024-06-07
Recruiting
Immunological Characteristics of Preclinical IBD
NCT05698745Crohn Disease, Ulcerative Colitis, IBD
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Observational
450
Santiago de Compostela, Badalona, Manresa, Terrassa, Donostia / San Sebastian, Vigo, Gijón, Oviedo
2024-06-01
Recruiting
GELLC (Grupo Español de Leucemia Linfocítica Crónica)
Phase 2
34
Barcelona, L'Hospitalet de Llobregat, Santander, Las Palmas de Gran Canaria, Madrid, Murcia, Marbella, Oviedo
2024-05-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
450
Santander, A Coruña, Pamplona, Oviedo, Barcelona, Madrid
2024-05-03
Active, closed
Eli Lilly and Company
Phase 3
10,000
A Coruña, Almería, Alzira, Barcelona, Ferrol, Málaga, Oviedo, Palma de Mallorca
2024-04-30
Active, closed
Erasca, Inc.
Phase 3
78
Barcelona, Madrid, Oviedo
2024-04-29
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Badalona, El Palmar, Oviedo, Cáceres, Girona, Las Palmas de Gran Canaria, Salamanca, Valencia
2024-04-22
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
Avalyn Pharma Inc.
Phase 2
375
Granada, Barcelona, Santander, Madrid, Málaga, Oviedo, Seville, Cadiz
2024-04-03
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
Alexion Pharmaceuticals, Inc.
Phase 3
584
A Coruña, Alcalá de Henares, Lleida, Madrid, Málaga, Murcia, Oviedo, Seville
2024-03-29
Active, closed
Samsung Bioepis Co., Ltd.
Phase 3
555
Leganés, Málaga, Ourense, Oviedo, Santiago de Compostela, Seville, Valencia
2024-03-12
Recruiting
Kura Oncology, Inc.
Phase 1
171
Barcelona, Oviedo, Seville, Valencia
2024-02-22
Active, closed
AbbVie
Observational
1,200
Sant Joan Despí, Jerez de la Frontera, Córdoba, Las Palmas de Gran Canaria, Leganés, Oviedo, Galdakao, Barcelona
2024-02-19
Active, closed
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
Mirati Therapeutics Inc.
Phase 2
200
Santiago de Compostela, Málaga, Palma de Mallorca, Oviedo, Barcelona, Madrid, Seville, Valencia
2024-02-01
Not yet open
Fundacion Clinic per a la Recerca Biomédica
Early Phase 1
40
Santiago de Compostela, Barcelona, Madrid, Murcia, Oviedo, Palma de Mallorca, Salamanca
2024-01-15
Recruiting
Hospital Universitario Central de Asturias
Observational
100
A Coruña, Badalona, Barcelona, Burgos, Donostia / San Sebastian, Madrid, Málaga, Oviedo
2024-01-12
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Santiago de Compostela, Palma, L'Hospitalet de Llobregat, Santander, Pozuelo de Alarcón, Oviedo, Barcelona, Granada
2023-12-28
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
149
Badalona, Pozuelo de Alarcón, Pamplona, Oviedo, Alicante, Barcelona, Madrid, Salamanca
2023-12-19
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
54
Barcelona, Vigo, Valencia, Madrid, Oviedo, Seville
2023-12-13
Active, closed
Syndax Pharmaceuticals
Phase 2
145
L'Hospitalet de Llobregat, Sabadell, Santander, Majadahonda, Oviedo, Barcelona, Cadiz, Girona
2023-12-11
Active, closed
Sanofi
Phase 2
197
Barcelona, Esplugues de Llobregat, Oviedo, Seville, Málaga, Valencia, Vitoria-Gasteiz
2023-12-11
Active, closed
argenx
Observational
413
Alicante, Badalona, Barcelona, Bilbao, L'Hospitalet de Llobregat, Oviedo, Pamplona, San Sebastián
2023-11-29
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Seville, Sabadell, Terrassa, Barakaldo, Majadahonda, Pozuelo de Alarcón, Pamplona, Oviedo
2023-11-14
Active, closed
AstraZeneca
Phase 3
863
Barakaldo, Barcelona, Madrid, Oviedo
2023-11-09
Active, closed
TheraSphere With Durvalumab and Tremelimumab for HCC
NCT05063565Hepatocellular Carcinoma
Boston Scientific Corporation
Phase 2
100
Barcelona, Pamplona, Oviedo, Madrid, Valencia, Valladolid
2023-11-03
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
170
Seville, L'Hospitalet de Llobregat, Santiago de Compostela, Madrid, Oviedo, Valencia, Barcelona
2023-10-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Badalona, Barcelona, Santander, Santiago de Compostela, Málaga, Madrid, Majadahonda, Oviedo
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
402
Barcelona, L'Hospitalet de Llobregat, Valencia, Granada, Madrid, Oviedo, Salamanca, Seville
2023-10-24
Active, closed
Genentech, Inc.
Phase 2
260
Badalona, Málaga, Pamplona/iruña, Oviedo, Barcelona, Madrid
2023-10-18
Active, closed
Ad scientiam
Not applicable
336
Girona, Madrid, Málaga, Oviedo, Zaragoza
2023-09-22
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Santander, Santiago de Compostela, Madrid, Majadahonda, Barcelona, Girona, Oviedo, Pamplona
2023-09-14
Active, closed
Hoffmann-La Roche
Phase 3
687
Navarra, Pamplona/iruña, Oviedo, Barcelona, Jaén, Madrid, Valencia
2023-09-14
Recruiting
Biotest
Phase 3
590
Palma de Mallorca, Sabadell, Terrassa, Córdoba, Majadahonda, Pamplona, Oviedo, Barcelona
2023-09-09
Recruiting
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Not applicable
900
Santiago de Compostela, L'Hospitalet de Llobregat, Sabadell, A Coruña, Majadahonda, Oviedo, Alicante, Barcelona
2023-09-06
Recruiting
The ReTAVI Prospective Observational Registry
NCT05601453Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction
Institut für Pharmakologie und Präventive Medizin
Observational
250
Barcelona, León, Madrid, Oviedo, Vigo
2023-09-05
Active, closed
Emalex Biosciences Inc.
Phase 3
150
Madrid, Oviedo, Seville
2023-08-16
Recruiting
P+F Products + Features GmbH
Not applicable
267
Barcelona, Madrid, Valladolid, Majadahonda, Málaga, Oviedo
2023-07-03
Active, closed
Regeneron Pharmaceuticals
Phase 2/3
149
Santiago de Compostela, Palma, Barcelona, Majadahonda, Oviedo, Madrid, Málaga, Seville
2023-06-30
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Barcelona, Cáceres, Las Palmas de Gran Canaria, Murcia, Oviedo, Valencia, Badalona, Madrid
2023-06-22
Recruiting
Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
NCT06889883Colorectal Carcinoma, Advanced Adenomas (AA)
ADVANCED MARKER DISCOVERY S.L.
Observational
510
Zaragoza, Bilbao, Donostia / San Sebastian, Santander, Salamanca, Barcelona, Madrid, Oviedo
2023-06-06
Recruiting
Usefulness of PET-CT for Invasive Fungal Infection
NCT05688592Invasive Fungal Infections
Puerta de Hierro University Hospital
Observational
224
Majadahonda, Barcelona, Granada, Madrid, Málaga, Murcia, Oviedo, Salamanca
2023-04-27
Recruiting
ADVANCED MARKER DISCOVERY S.L.
Observational
250
Málaga, Oviedo, Ourense, Madrid
2023-04-17
Recruiting
ReGenTree, LLC
Phase 3
70
Barcelona, Córdoba, Oviedo, Valencia
2023-04-11
Active, closed
Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation
NCT05758909Aortic Valve Disease, Aortic Valve Stenosis, Heart Valve Diseases
Fundación EPIC
Observational
585
A Coruña, Alicante, Aravaca, Badalona, Barcelona, L'Hospitalet de Llobregat, Málaga, Oviedo
2023-04-04
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Badalona, Jerez de la Frontera, L'Hospitalet de Llobregat, León, Madrid, Murcia, Oviedo, Palma de Mallorca
2023-03-29
Recruiting
Novartis Pharmaceuticals
Phase 3
195
Pamplona, Oviedo, A Coruña, Córdoba
2023-02-10
Recruiting
Medtronic Cardiovascular
Not applicable
400
Barcelona, Madrid, Oviedo, Vigo
2023-02-07
Recruiting
Poitiers University Hospital
Not applicable
670
Barcelona, L'Hospitalet de Llobregat, Oviedo, Toledo
2023-02-02
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Badalona, Santander, Barcelona, Oviedo, Granada, Lugo, Madrid, Seville
2023-01-16
Active, closed
Exelixis
Phase 3
317
Palma de Mallorca, Majadahonda, Barcelona, Córdoba, Girona, Madrid, Málaga, Oviedo
2023-01-01
Recruiting
Iperboreal Pharma Srl
Phase 3
170
A Coruña, Badalona, Barcelona, Girona, Madrid, Oviedo
2022-12-14
Active, closed
Redx Pharma Ltd
Phase 2
48
Barcelona, Madrid, Oviedo, Santander, Santiago de Compostela
2022-09-08
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
United Therapeutics
Phase 3
1,850
Santiago de Compostela, Palma de Mallorca, L'Hospitalet de Llobregat, Málaga, Oviedo, Barcelona, Granada, Madrid
2022-09-06
Recruiting
Bristol-Myers Squibb
Observational
1,700
Palma de Mallorca, Majadahonda, El Palmar, Oviedo, Burgos, Madrid, Málaga
2022-08-16
Recruiting
Perpetual Observational Study - Ventilator Associated Pneumonia
NCT05719259Ventilator Associated Pneumonia
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Observational
20,000
Córdoba, Oviedo, Burjassot, Barcelona
2022-08-03
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Córdoba, Badalona, Barcelona, Donostia / San Sebastian, El Palmar, Oviedo, A Coruña, Girona
2022-07-14
Recruiting
Octapharma
Phase 3
38
Oviedo, Madrid, Murcia, Ourense
2022-07-01
Active, closed
Novartis Pharmaceuticals
Phase 3
95
Pamplona, Oviedo, Córdoba, Madrid
2022-06-15
Recruiting
Fundación Academia Española de Dermatología
Observational
7,000
Badalona, A Coruña, Barcelona, Córdoba, Las Palmas, León, Madrid, Oviedo
2022-06-01
Active, closed
University of Oviedo
Not applicable
48
Oviedo
2022-05-25
Active, closed
IO Biotech
Phase 3
407
Seville, A Coruña, Barcelona, Madrid, Málaga, Oviedo, Pamplona, Valencia
2022-05-17
Recruiting
Innovacell GmbH
Phase 3
290
Barcelona, Mataró, Murcia, Oviedo
2022-05-11
Active, closed
University of Oviedo
Not applicable
153
Oviedo
2022-05-01
Recruiting
Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
NCT05114850Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Insufficiency, Heart Failure
P+F Products + Features GmbH
Observational
450
Galdakao, Málaga, Barcelona, Córdoba, Lugo, Madrid, Oviedo, Salamanca
2022-04-20
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Barcelona, Madrid, Oviedo, Málaga, Valencia, Zaragoza
2022-03-29
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
NCT04988555Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma, Myelodysplastic Syndromes
Sumitomo Pharma America, Inc.
Phase 1/2
606
Albacete, Barcelona, Cáceres, Las Palmas, Madrid, Oviedo, Salamanca, Santander
2022-02-28
Active, closed
Annetine Gelijns
Not applicable
450
Palma de Mallorca, Vigo, Barcelona, Madrid, Oviedo
2022-02-21
Recruiting
ARCAGY/ GINECO GROUP
Phase 2
390
A Coruña, Barcelona, Cáceres, El Palmar, Murcia, Jerez de la Frontera, Madrid, Málaga, Oviedo
2022-02-01
Active, closed
Ascendis Pharma Oncology Division A/S
Phase 1/2
320
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Murcia, Oviedo, Pamplona, Seville
2022-01-11
Active, closed
ITM Solucin GmbH
Phase 3
259
Barcelona, Madrid, Oviedo, Santiago de Compostela, Valencia
2021-12-21
Active, closed
PETHEMA Foundation
Phase 1/2
60
Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Murcia, Oviedo, Palma de Mallorca, Pamplona
2021-12-20
Active, closed
Novartis Pharmaceuticals
Phase 3
210
Badajoz, Pozuelo de Alarcón, Oviedo, A Coruña, Barcelona, Madrid, Málaga, Zaragoza
2021-12-17
Active, closed
GWT-TUD GmbH
Phase 3
70
Badalona, Barcelona, Madrid, Oviedo, Salamanca, Valencia
2021-10-27
Active, closed
Camurus AB
Phase 3
332
A Coruña, Barcelona, Elche, Girona, Madrid, Málaga, Murcia, Oviedo
2021-10-22
Active, closed
Loxo Oncology, Inc.
Phase 3
282
Madrid, Oviedo, Barcelona, Seville
2021-09-23
Active, closed
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT04850105Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics
Observational
202
Huelva, Oviedo, Palma de Mallorca, Villarreal, Barcelona, Madrid
2021-09-21
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Barcelona, Madrid, Majadahonda, Marbella, Oviedo, Pozuelo de Alarcón, Seville, Toledo
2021-09-20
Active, closed
AstraZeneca
Phase 3
98
Alicante, Barcelona, Córdoba, León, Madrid, Málaga, Murcia, Oviedo
2021-09-12
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
NCT05086692Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma, Triple Negative Breast Cancer
Medicenna Therapeutics, Inc.
Phase 1/2
115
Badalona, Barcelona, Madrid, Oviedo, Torrejón
2021-08-27
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
A Coruña, Algeciras / Cadiz, Barcelona, Bilbao, Córdoba, Granada, Madrid, Oviedo
2021-08-25
Active, closed
Merck Sharp & Dohme LLC
Phase 2
730
Badalona, Santiago de Compostela, Madrid, Oviedo, Barcelona
2021-08-18
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Madrid, Oviedo, Barcelona
2021-08-12
Active, closed
Hoffmann-La Roche
Phase 3
451
L'Hospitalet de Llobregat, San Cugat Del Valles, Majadahonda, Pamplona, Oviedo, Barcelona, Córdoba, Madrid
2021-07-14
Recruiting
Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform
NCT04927156Intracranial Aneurysm, Brain Arterial Disease, Acute Ischemic Stroke, Peripheral Vascular Diseases
Balt Extrusion
Observational
10,000
Madrid, Oviedo, Santander, Zaragoza
2021-07-12
Active, closed
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
NCT05027984Coronary Artery Disease, Coronary Disease, Ischemic Heart Disease
Centro per la Lotta Contro l'Infarto - Fondazione Onlus
Not applicable
1,425
Málaga, Madrid, Oviedo
2021-06-30
Active, closed
Pfizer
Phase 3
599
Elche, Badalona, L'Hospitalet de Llobregat, Manresa, Lugo, Majadahonda, Pamplona, Oviedo
2021-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Badalona, Manresa, Girona, Santiago de Compostela, Las Palmas de Gran Canaria, Oviedo, Valencia, Barcelona
2021-04-21
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
Novartis Pharmaceuticals
Phase 3
430
Oviedo, Badalona, Barcelona, Cáceres, Las Palmas de Gran Canaria, Madrid, Murcia, Salamanca
2021-04-09
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Cáceres, Oviedo, Zaragoza, Badalona, Barcelona, Girona, Las Palmas de Gran Canaria, Lugo
2021-03-11
Active, closed
German CLL Study Group
Phase 3
897
Badalona, Barcelona, Madrid, Málaga, Oviedo, Salamanca, Santander, Seville
2021-03-01
Active, closed
Taiho Oncology, Inc.
Phase 1/2
101
Oviedo, L'Hospitalet de Llobregat, Pamplona, Madrid, Salamanca, Valencia
2021-02-09
Active, closed
Sellas Life Sciences Group
Phase 3
127
Cáceres, Córdoba, Madrid, Oviedo, Pamplona, Salamanca, Seville, Valencia
2021-02-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
L'Hospitalet de Llobregat, Oviedo, Barcelona, Madrid, Málaga, Seville
2020-12-08
Active, closed
Instituto de Investigación Hospital Universitario La Paz
Phase 1/2
18
Santiago de Compostela, Oviedo, Barcelona, Madrid, Málaga, Murcia, Seville, Valencia
2020-11-30
Active, closed
Bayer
Phase 4
654
Santiago de Compostela, Palma de Mallorca, Badalona, Castellon, Majadahonda, Oviedo, A Coruña, Barcelona
2020-11-09
Active, closed
Exelixis
Phase 3
575
Elche, Palma de Mallorca, Manresa, Santiago de Compostela, Alcorcón, Oviedo, Badalona, Barcelona
2020-10-19
Active, closed
AbbVie
Phase 3
527
Ferrol, Santiago de Compostela, Badalona, L'Hospitalet de Llobregat, Fuenlabrada, Majadahonda, Oviedo, Alicante
2020-09-30
Active, closed
AbbVie
Phase 3
330
A Coruña, Santiago de Compostela, Badalona, Las Palmas de Gran Canaria, Oviedo, Barcelona, Granada, Madrid
2020-08-31
Active, closed
AstraZeneca
Phase 3
1,012
Badalona (Barcelona), Barcelona, Las Palmas de Gran Canaria, Madrid, Oviedo, Santander, Seville
2020-07-13
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
NCT04256317Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm, Chronic Myelomonocytic Leukemia
Taiho Oncology, Inc.
Phase 2/3
316
Badalona, L'Hospitalet de Llobregat, Pamplona, Oviedo, Barcelona, Cáceres, Girona, Granada
2020-05-21
Recruiting
Terumo Aortic Global Endovascular Registry
NCT04246463Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Surgery
Vascutek Ltd.
Observational
1,000
Badalona, Barcelona, Oviedo
2019-12-17
Active, closed
CStone Pharmaceuticals
Phase 3
534
A Coruña, Ourense, Majadahonda, Oviedo, Ávila, Barcelona, Burgos, Girona
2019-12-13
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
Novo Nordisk A/S
Phase 3
156
Madrid, Málaga, Oviedo, Seville, Valencia
2019-11-13
Active, closed
Inotrem
Phase 2
355
Barcelona, Madrid, Oviedo, Terrassa, Valencia
2019-11-13
Active, closed
Balt Extrusion
Observational
234
Barakaldo, Madrid, Oviedo, Valladolid
2019-11-04
Recruiting
Boston Scientific Corporation
Observational
500
Barcelona, Oviedo
2019-10-23
Active, closed
Novo Nordisk A/S
Phase 3
134
Barcelona, Madrid, Málaga, Oviedo, Seville
2019-10-21
Active, closed
NeuroDerm Ltd.
Phase 3
381
Oviedo, Alicante, Barcelona, Burgos, Madrid, Seville, Valencia
2019-09-30
Active, closed
Spanish Oncology Genito-Urinary Group
Phase 2
39
Manresa, Sabadell, Reus, Granada, Lugo, Madrid, Ourense, Oviedo
2019-09-18
Active, closed
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
NCT04067336Advanced Malignant Neoplasm, Acute Myeloid Leukemia, Mixed Lineage Leukemia, Mixed Lineage Acute Leukemia
Kura Oncology, Inc.
Phase 1/2
263
Barcelona, Madrid, Oviedo, Seville, Valencia
2019-09-12
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene
Phase 3
665
Barakaldo, Barcelona, Madrid, Oviedo, Salamanca, Seville, Valencia
2019-08-12
Active, closed
Dentsply Sirona Implants and Consumables
Not applicable
160
Cheste, Oviedo
2019-07-30
Active, closed
Exelixis
Phase 3
855
Santiago de Compostela, Pamplona, Barcelona, Córdoba, Madrid, Oviedo, Valencia
2019-06-25
Active, closed
Sanofi
Observational
955
Bilbao, Las Palmas de Gran Canaria, Majadahonda, Oviedo, Barakaldo, Barcelona, Madrid, Santiago de Compostela
2019-06-11
Recruiting
Aptose Biosciences Inc.
Phase 1/2
240
Barcelona, Pozuelo de Alarcón, Oviedo, Valencia
2019-03-11
Active, closed
W.L.Gore & Associates
Observational
280
Oviedo, Santiago de Compostela
2018-12-18
Active, closed
AstraZeneca
Phase 3
825
Alicante, Barcelona, Donostia / San Sebastian, Madrid, Málaga, Oviedo, Pamplona, Santiago de Compostela (A Coruña)
2018-12-06
Active, closed
AstraZeneca
Phase 3
730
Barcelona, Madrid, Oviedo, Seville, Valencia, Zaragoza
2018-09-27
Recruiting
Hoffmann-La Roche
Phase 3
1,000
L'Hospitalet de Llobregat, San Cugat Del Valles, Majadahonda, Pamplona, Oviedo, Burjassot, Barcelona, Córdoba
2018-09-20
Active, closed
Eli Lilly and Company
Phase 3
1,058
Alicante, Fuenlabrada, Girona, Huelva, Las Palmas de GC, Madrid, Oviedo, Sagunto
2018-07-18
Active, closed
PETHEMA Foundation
Phase 2
62
Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Murcia, Oviedo, Pamplona
2018-07-15
Active, closed
Memorial Sloan Kettering Cancer Center
Phase 3
732
Oviedo, Madrid, Barcelona, Castellon, Seville, Valencia
2018-06-19
Active, closed
pharmaand GmbH
Phase 3
1,097
Barcelona, Bilbao, Castillón, El Palmar, Jerez de la Frontera, Madrid, Oviedo, Palma de Mallorca
2018-05-14
Active, closed
AstraZeneca
Phase 3
1,018
Badajoz, Barcelona, Elche(Alicante), Madrid, Málaga, Oviedo, Pamplona, Pozuelo de Alarcón
2018-05-14
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Córdoba, Ferrol, Girona, Huelva, Madrid, Oviedo, Pontevedra, Seville
2018-04-13
Active, closed
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
NCT02984410Oropharyngeal Cancer, Supraglottic Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
112
Barcelona, Madrid, Oviedo
2017-11-27
Active, closed
AstraZeneca
Phase 3
1,324
Barcelona, Madrid, Oviedo, Pamplona Madrid, Santander
2017-10-11
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Barakaldo, Barcelona, Cartagena, El Palmar, Esplugues de Llobregat, Las Palmas de Gran Canaria, Madrid, Oviedo
2017-09-12
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
Exelixis
Phase 1
914
Santiago de Compostela, Elche, Palma de Mallorca, Badalona, Sabadell, Jeréz de La Frontera, Pamplona, Oviedo
2017-09-05
Active, closed
Henares University Hospital
Observational
200
Arganda, Avilés, Oviedo, Talavera de la Reina, Madrid
2017-09-01
Recruiting
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Barcelona, Málaga, Valencia, Badalona, Castellon, Madrid, Oviedo, Zaragoza
2017-07-21
Active, closed
ITM Solucin GmbH
Phase 3
324
Barcelona, Madrid, Oviedo, Valencia
2017-02-02
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Barakaldo, Barcelona, Madrid, Oviedo, San Sebastián, Seville, Valladolid, Vigo
2016-12
Active, closed
Eisai Inc.
Phase 3
1,069
Santander, Barcelona, Cáceres, Córdoba, Madrid, Oviedo, Seville, Valencia
2016-10-13
Recruiting
Boston Scientific Corporation
Observational
300
Barcelona, El Palmar, Madrid, Oviedo
2016-03-07
Active, closed
PETHEMA Foundation
Phase 2
90
Barcelona, Madrid, Murcia, Oviedo, Pamplona, Plama de Mallorca, Salamanca, Santa Cruz de Tenerife
2015-05
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
El Palmar, Barcelona, Donostia / San Sebastian, Girona, Madrid, Málaga, Oviedo, Palma
2014-12-04
Recruiting
Boston Scientific Corporation
Observational
1,500
Barcelona, Madrid, Murcia, Oviedo, Valencia
2014-03-04
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Santiago de Compostela, Barakaldo, Logroño, Burela de Cabo, Málaga, Oviedo, Reus, A Coruña
2013-05-30
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Barcelona, Málaga, Murcia, Oviedo
2013-04
Recruiting
Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)
NCT06911099Atrial Functional Mitral Regurgitation, Mitral Insufficiency
University Hospital of Cologne
Observational
1,000
Barcelona, Córdoba, León, Oviedo, Vigo
2010-01-01
Rows per page Showing 1–233 of 233
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/oviedo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 233 of those studies with a site in Oviedo.

How many clinical trials are recruiting in Oviedo?

100 of the 233 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 14 have not yet opened recruitment, 116 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Oviedo), 233 studies
PhaseStudiesRecruitingShare
Phase 31003342.9%
Observational503021.5%
Phase 2311113.3%
Not applicable241010.3%
Phase 1/21265.2%
Phase 2/3963.9%
Phase 4431.7%
Phase 1210.9%
Early Phase 1100.4%

Most active sponsors

Lead sponsors with the most studies (Oviedo)
Lead sponsorStudiesRecruiting
AstraZeneca145
University of Oviedo111
Merck Sharp & Dohme LLC104
Regeneron Pharmaceuticals83
Bristol-Myers Squibb71
Eli Lilly and Company64
Exelixis51
Investigación en Hemofilia y Fisioterapia52
Novartis Pharmaceuticals52
Sanofi51
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.